Share delivers predictive biomarkers as a basis for decision support in precision medicine. They use novel, state of the art, machine learning approaches specifically designed to find complex patterns in biomedical data.

Focus: Genomics-focused drug discovery platform 

Team: Joern Klinger (CEO) and Marco Schmidt (CSO)


Be part of SBC Catalyser 2024!

Spaces are limited to 10 companies per cohort, apply to the free programme by clicking the button below, or learn more by writing to


We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.